Parallel Enforcement: SEC Authorities and How they can Impact FDA’s Civil and Criminal Enforcement

Goodwin FDA partner Susan Lee is speaking at the Food and Drug Law Institute (FDLI) Food and Drug Law Journal 2022 Symposium. Susan will join colleagues from Cooley and Shook, Hardy & Bacon to discuss the "Parallel Enforcement: SEC Authorities and How they can Impact FDA's Civil and Criminal Enforcement" paper.